← Back to ANAB

AnaptysBio, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSMar 2026Filed 12/05/2026Sep 2025Filed 04/11/2025Jun 2025Filed 04/11/2025Mar 2025Filed 12/05/2026Sep 2024Filed 04/11/2025Jun 2024Filed 04/11/2025Mar 2024Filed 04/11/2025Sep 2023Filed 05/11/2024
$26$76$22$28$30$11$7.2$3.3
−$53$15−$39−$39−$33−$47−$44−$37
−$1.84$0.52−$1.34−$1.28−$1.14−$1.71−$1.64−$1.41
2929293129272727

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.